Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - February 2005

  1. Polio Vaccination Campaign Reaches Over 95% of Children Under Five in Iraq.   Ann Saudi Med; 24 (6): 492; November, 2004.

  2. Largest Ever Polio Vaccination Campaign.   Bull World Health Organ; 82 (11): 890; November, 2004.

  3. Two Countries Re-Infected With Polio, As Nigerian State Resumes Vaccinations.   Bull World Health Organ; 82 (9): 717; September, 2004.

  4. Diphtheria, Tetanus and Pertussis Vaccine.   Nurs Times; 100 (47): 35; November 23, 2004.

  5. Establishment of Vaccination Clinics; User Fees for Investigational New Drug (IND) Influenza Vaccine Services and Vaccines. Interim Final Rule and Request for Comments.   Fed Regist; 70 (15): 3490-3493; January 25, 2005.

  6. [Mass Vaccination Campaign Against Serogroup C Meningococcal Disease, Municipality of Itapeva, Sao Paulo.].   Rev Saude Publica; 39 (1): 139-140; January, 2005.

  7. HHS-CDC NEWS: Recommended Childhood and Adolescent Immunization Schedule--US, 2005.   Ann Pharmacother; 39 (2): 396; February, 2005.

  8. Recommended Childhood and Adolescent Immunization Schedule: United States, 2005.   Pediatrics; 115 (1): 182; January, 2005.

  9. Andrade, A. L.; Martelli, C. M.  Globalisation of Hib Vaccination--How Far Are We?   Lancet; 365 (9453): 5-7; January 1, 2005.

  10. Angoulvant, F.; Bidet, P.; Doit, C.; Aubertin, G.; Soussan, V.; Bingen, E.; Bourrillon, A.; Faye, A.  Serotype 6B Pneumococcal Meningitis in an Immunocompetent Infant Immunized With Heptavalent Pneumococcal Conjugated Vaccine.   Clin Infect Dis; 40 (3): 494-495; February 1, 2005.

  11. Baltimore, R. S.; Jenson, H. B.  The Immunization Schedule Confronts Adolescence.   Curr Opin Pediatr; 17 (1): 54-55; February, 2005.

  12. Barker, L. E.; Smith, P. J.; Gerzoff, R. B.; Luman, E. T.; McCauley, M. M.; Strine, T. W.  Ranking States' Immunization Coverage: an Example From the National Immunization Survey.   Stat Med; 24 (4): 605-613; January 28, 2005.

  13. Batt, K.; Fox-Rushby, J. A.; Castillo-Riquelme, M.  The Costs, Effects and Cost-Effectiveness of Strategies to Increase Coverage of Routine Immunizations in Low- and Middle-Income Countries: Systematic Review of the Grey Literature.   Bull World Health Organ; 82 (9): 689-696; September, 2004.

  14. Bennett, D. A.; Holtzman, D. M.  Immunization Therapy for Alzheimer Disease?   Neurology; 64 (1): 10-12; January 11, 2005.

  15. Bergeron, B.  To Vaccinate or Not to Vaccinate: Rubella and the Adult Woman.   Midwifery Today Int Midwife; 72: 48-49; Winter 2004.

  16. Bernsen, R. M.; van der Wouden, J. C.  Re: No Epidemiological Evidence for Infant Vaccinations to Cause Allergic Disease.  Vaccine; 23 (12): 1427; February 10, 2005.

  17. Bogaert, D.; Veenhoven, R. H.; Sluijter, M.; Wannet, W. J.; Rijkers, G. T.; Mitchell, T. J.; Clarke, S. C.; Goessens, W. H.; Schilder, A. G.; Sanders, E. A.; de, Groot R.; Hermans, P. W.  Molecular Epidemiology of Pneumococcal Colonization in Response to Pneumococcal Conjugate Vaccination in Children With Recurrent Acute Otitis Media.   J Clin Microbiol; 43 (1): 74-83; January, 2005.

  18. Brydak, L. B.; Tadeusz, S.; Magdalena, M.  Antibody Response to Influenza Vaccination in Healthy Adults.   Viral Immunol; 17 (4): 609-615; 2004.

  19. Bueving, H. J.; Thomas, S.; Wouden, J. C.  Is Influenza Vaccination in Asthma Helpful?   Curr Opin Allergy Clin Immunol; 5 (1): 65-70; February, 2005.

  20. Chen, C. S.; Liu, T. C.  The Taiwan National Health Insurance Program and Full Infant Immunization Coverage.   Am J Public Health; 95 (2): 305-311; February, 2005.

  21. Crowe, S. R.; Miller, S. C.; Shenyo, R. M.; Woodland, D. L.  Vaccination With an Acidic Polymerase Epitope of Influenza Virus Elicits a Potent Antiviral T Cell Response but Delayed Clearance of an Influenza Virus Challenge.   J Immunol; 174 (2): 696-701; January 15, 2005.

  22. Cunha, S. S.; Camacho, L. A.; Santos, A. C.; Dourado, I.  Influenza Vaccination in Brazil: Rationale and Caveats.   Rev Saude Publica; 39 (1): 129-136; January, 2005.

  23. Dietz, V.; Venczel, L.; Izurieta, H.; Stroh, G.; Zell, E. R.; Monterroso, E.; Tambini, G.  Assessing and Monitoring Vaccination Coverage Levels: Lessons From the Americas.   Rev Panam Salud Publica; 16 (6): 432-442; December, 2004. VAERS

  24. Eggertson, L.  Vaccinating the World: How Likely?   CMAJ; 172 (1): 24; January 4, 2005.

  25. Fox-Rushby, J. A.; Kaddar, M.; Levine, R.; Brenzel, L.  The Economics of Vaccination in Low- and Middle-Income Countries.   Bull World Health Organ; 82 (9): 640; September, 2004.

  26. Francisco, P. M.; Donalisio, M. R.; Lattorre, Mdo R.  [Impact of Influenza Vaccination on Mortality by Respiratory Diseases Among Brazilian Elderly Persons.].   Rev Saude Publica; 39 (1): 75-81; January, 2005.

  27. Gami, A. S.; Murphy, J.; Cooper, L. T., Jr.  Cautious Interpretation of Data Regarding Myopericarditis Associated With Smallpox Vaccination.   J Am Coll Cardiol; 45 (1): 160-161; January 4, 2005.

  28. Gershon, A.  Contagiousness of Varicella in Vaccinated Cases: A Household Contact Study.   J Pediatr; 146 (1): 147; January, 2005.

  29. Griffiths, U. K.; Wolfson, L. J.; Quddus, A.; Younus, M.; Hafiz, R. A.  Incremental Cost-Effectiveness of Supplementary Immunization Activities to Prevent Neonatal Tetanus in Pakistan.   Bull World Health Organ; 82 (9): 643-651; September, 2004.

  30. Gulati, U.; Kumari, K.; Wu, W.; Keitel, W. A.; Air, G. M.  Amount and Avidity of Serum Antibodies Against Native Glycoproteins and Denatured Virus After Repeated Influenza Whole-Virus Vaccination. Vaccine; 23 (11): 1414-1425; February 3, 2005.

  31. Hill, T.; Platzer, A.; Reyes, C.  Influenza Deaths in Spite of Immunization and Prophylaxis.   Clin Infect Dis; 40 (3): 492-493; February 1, 2005.

  32. Kaddar, M.; Lydon, P.; Levine, R.  Financial Challenges of Immunization: a Look at GAVI.   Bull World Health Organ; 82 (9): 697-702; September, 2004.

  33. Kanra, G.; Isik, P.; Kara, A.; Cengiz, A. B.; Secmeer, G.; Ceyhan, M.  Complementary Findings in Clinical and Epidemiologic Features of Mumps and Mumps Meningoencephalitis in Children Without Mumps Vaccination.   Pediatr Int; 46 (6): 663-668; December, 2004.

  34. Kempe, A.; Daley, M. F.; Barrow, J.; Allred, N.; Hester, N.; Beaty, B. L.; Crane, L. A.; Pearson, K.; Berman, S.  Implementation of Universal Influenza Immunization Recommendations for Healthy Young Children: Results of a Randomized, Controlled Trial With Registry-Based Recall.   Pediatrics; 115 (1): 146-154; January, 2005.

  35. Khan, M. M.; Khan, S. H.; Walker, D.; Fox-Rushby, J.; Cutts, F.; Akramuzzaman, S. M.  Cost of Delivering Child Immunization Services in Urban Bangladesh: a Study Based on Facility-Level Surveys.   J Health Popul Nutr; 22 (4): 404-412; December, 2004.

  36. Kuno-Sakai, H.; Kimura, M.  Safety and Efficacy of Acellular Pertussis Vaccine in Japan, Evaluated by 23 Years of Its Use for Routine Immunization.   Pediatr Int; 46 (6): 650-655; December, 2004.

  37. Lalosevic, D.; Lalosevic, V.; Saric, M.; Mazibrada, J.; Babovic, S.; Sekulic, S.; Mitic, Z.  [Fatal Outcome After Postexposure Rabies Vaccination in a Patient With Parkinson's Disease].   Med Pregl; 57 (9-10): 487-492; September, 2004.

  38. Leibovitz, E.; Jacobs, M. R.; Dagan, R.  Haemophilus Influenzae: a Significant Pathogen in Acute Otitis Media.   Pediatr Infect Dis J; 23 (12): 1142-1152; December, 2004.

  39. Lepine, P.  [Evolution of Rabies Vaccination].   Bull Acad Natl Med; 163 (3): 265-271; March, 1979.

  40. Malmvall, B. E.; Abom, P. E.  [Influenza Vaccination for All Older Than 65 Years--Utopia or Possibility].   Lakartidningen; 101 (51-52): 4196-1; December 23, 2004.

  41. Mande, R.  [Rubella Immunization].   Bull Acad Natl Med; 163 (3): 272-276; March, 1979.

  42. McMahon, A. W.; Bryant-Genevier, M. C.; Woo, E. J.; Braun, M. M.; Ball, R.  Photophobia Following Smallpox Vaccination.   Vaccine; 23 (9): 1097-1098; January, 2005. VAERS

  43. Mercier, P.; Antoine, H. M.  [Should Typhoid-Paratyphoid Vaccination Be Continued?].   Bull Acad Natl Med; 163 (5): 446-450; May, 1979.

  44. Mohan, P.  Inequities in Coverage of Preventive Child Health Interventions: the Rural Drinking Water Supply Program and the Universal Immunization Program in Rajasthan, India.   Am J Public Health; 95 (2): 241-244; February, 2005.

  45. Muller, D.; Wutzler, P.; Szucs, T. D.  Influenza Vaccination Coverage Rates in Germany A Population-Based Cross-Sectional Analysis of the Seasons 2002/2003 and 2003/2004.   Med Klin (Munich); 100 (1): 6-13; January, 2005.

  46. Ovsyannikova, I. G.; Jacobson, R. M.; Vierkant, R. A.; Jacobsen, S. J.; Pankratz, V. S.; Poland, G. A.  Human Leukocyte Antigen Class II Alleles and Rubella-Specific Humoral and Cell-Mediated Immunity Following Measles-Mumps-Rubella-II Vaccination.   J Infect Dis; 191 (4): 515-519; February 15, 2005.

  47. Palenik, C. J.; Govoni, M.  An Immunization Program for Dental Practices.   Compend Contin Educ Dent; 25 (1 Suppl): 17-22; January, 2004.

  48. Pallasch, G.; Salman, R.; Hartwig, C.  [Improvement of Protection Given by Vaccination for Socially Underprivileged Groups on the Basis of "Key Persons Approach" - Results of an Intervention Based on Cultural and Language Aspects for Children of Immigrants in Altlander Viertel Provided by the Health Department of Stade.]. Gesundheitswesen; 67 (1): 33-38; January, 2005.

  49. Papadouka, V.; Schaeffer, P.; Metroka, A.; Borthwick, A.; Tehranifar, P.; Leighton, J.; Aponte, A.; Liao, R.; Ternier, A.; Friedman, S.; Arzt, N.  Integrating the New York Citywide Immunization Registry and the Childhood Blood Lead Registry.   J Public Health Manag Pract; Suppl: S72-S80; November, 2004.

  50. Pei, H.; Liu, J.; Cheng, Y.; Sun, C.; Wang, C.; Lu, Y.; Ding, J.; Zhou, J.; Xiang, H.  Expression of SARS-Coronavirus Nucleocapsid Protein in Escherichia Coli and Lactococcus Lactis for Serodiagnosis and Mucosal Vaccination.   Appl Microbiol Biotechnol; January, 2005. [Epub ahead of print]

  51. Prevots, D. R.; Pascual, F. B.; Angellili, M. L.; Brayden, R.; Irigoyen, M.; Larussa, P.; Sawyer, M.; Baughman, A. L.; Pallansch, M. A.  Population Immunity to Polioviruses Among Preschool Children From Four Urban Underserved Low Income Communities, United States, 1997-2001.   Pediatr Infect Dis J; 23 (12): 1130-1136; December, 2004.

  52. Rothberg, M. B.; Rose, D. N.  Vaccination Versus Treatment of Influenza in Working Adults: a Cost-Effectiveness Analysis.   Am J Med; 118 (1): 68-77; January, 2005.

  53. Saarlas, K. N.; Hinman, A. R.; Ross, D. A.; Watson, W. C., Jr.; Wild, E. L.; Hastings, T. M.; Richmond, P. A.  All Kids Count 1991-2004: Developing Information Systems to Improve Child Health and the Delivery of Immunizations and Preventive Services.   J Public Health Manag Pract; Suppl: S3-15; November, 2004.

  54. Saenger, R.; Maechler, G.; Potreck, M.; Zepp, F.; Knuf, M.; Habermehl, P.; Schuerman, L.  Booster Vaccination With Hexavalent DTPa-HBV-IPV/Hib Vaccine in the Second Year of Life Is As Safe As Concomitant DTPa-IPV/Hib + HBV Administered Separately. Vaccine; 23 (9): 1135-1143; January, 2005.

  55. Schutze, G. E.; Tucker, N. C.; Mason, E. O., Jr.  Impact of the Conjugate Pneumococcal Vaccine in Arkansas.   Pediatr Infect Dis J; 23 (12): 1125-1129; December, 2004.

  56. Schwartz, J. B.; Bhushan, I.  Improving Immunization Equity Through a Public-Private Partnership in Cambodia.   Bull World Health Organ; 82 (9): 661-667; September, 2004.

  57. Schweon, S. J.; Novatnack, E. S.  Fighting the Flu in the Face of a Shortage.   RN; 67 (12): 26-30; December, 2004.

  58. Sejvar, J.; Boneva, R.; Lane, J. M.; Iskander, J.  Severe Headaches Following Smallpox Vaccination.   Headache; 45 (1): 87-88; January, 2005. VAERS

  59. Sewell, W. A.  CCVID Patients May Not Respond to Influenza Immunization.   Clin Immunol; 114 (2): 210; February, 2005.

  60. Sikora, A.  [Safety of Vaccination in Connective Tissue Diseases]. Pol Arch Med Wewn; 112 (2): 1003-1008; August, 2004.

  61. Skowronski, D. M.; Bjornson, G.; Husain, E.; Metzger, D. L.; Scheifele, D. W.  Oculorespiratory Syndrome After Influenza Immunization in Children.   Pediatr Infect Dis J; 24 (1): 63-69; January, 2005.

  62. Steyer, T. E.; Mainous, A. G., III; Geesey, M. E.  The Effect of Race and Residence on the Receipt of Childhood Immunizations: 1993-2001. Vaccine; 23 (12): 1464-1470; February 10, 2005.

  63. Swart, B.  New Funding for Immunization in Canada.   Can Nurse; 100 (8): 14-15; October, 2004.

  64. Tabira, T.  [Vaccination Therapy for Alzheimer's Disease].   Nippon Ronen Igakkai Zasshi; 41 (6): 579-581; November, 2004.

  65. Triau, R.; Merieux, C.  [Against Meningococcus: a New Form of Vaccination].   Bull Acad Natl Med; 163 (3): 277-288; March, 1979.

  66. Valdespino-Gomez, J. L.; Garcia-Garcia, Mde L.  [Thirtieth Anniversary of the National Measles Vaccination Program in Mexico. The Great Benefits and Potential Risks].   Gac Med Mex; 140 (6): 639-641; November, 2004.

  67. Veirum, J. E.; Sodemann, M.; Biai, S.; Jakobsen, M.; Garly, M. L.; Hedegaard, K.; Jensen, H.; Aaby, P.  Routine Vaccinations Associated With Divergent Effects on Female and Male Mortality at the Paediatric Ward in Bissau, Guinea-Bissau.   Vaccine; 23 (9): 1197-1204; January, 2005.

  68. Vines, J.  [Smallpox Vaccinations in Navarre (Spain) Between September and November 1801.].   An Sist Sanit Navar; 27 (3): 359-371; September, 2004.

  69. Walker, D.; Mosqueira, N. R.; Penny, M. E.; Lanata, C. F.; Clark, A. D.; Sanderson, C. F.; Fox-Rushby, J. A.  Variation in the Costs of Delivering Routine Immunization Services in Peru.   Bull World Health Organ; 82 (9): 676-682; September, 2004.

  70. Waters, H. R.; Dougherty, L.; Tegang, S. P.; Tran, N.; Wiysonge, C. S.; Long, K.; Wolfe, N. D.; Burke, D. S.  Coverage and Costs of Childhood Immunizations in Cameroon.   Bull World Health Organ; 82 (9): 668-675; September, 2004.

  71. Weller, S.; Reynaud, C. A.; Weill, J. C.  Vaccination Against Encapsulated Bacteria in Humans: Paradoxes.   Trends Immunol; 26 (2): 85-89; February, 2005.

  72. Weycker, D.; Edelsberg, J.; Elizabeth, Halloran M.; Longini, I. M., Jr.; Nizam, A.; Ciuryla, V.; Oster, G.  Population-Wide Benefits of Routine Vaccination of Children Against Influenza.   Vaccine; 23 (10): 1284-1293; January 26, 2005.

  73. Winstock, A. R.  High Risk Groups Are Still Not Being Vaccinated. BMJ; 330 (7484): 198; January 22, 2005.

  74. Yameogo, K. R.; Perry, R. T.; Yameogo, A.; Kambire, C.; Konde, M. K.; Nshimirimana, D.; Kezaala, R.; Hersh, B. S.; Cairns, K. L.; Strebel, P.  Migration As a Risk Factor for Measles After a Mass Vaccination Campaign, Burkina Faso, 2002{Dagger}.   Int J Epidemiol; January, 2005. [Epub ahead of print]

  75. Zhang, Y.; Auranen, K.; Eichner, M.  The Influence of Competition and Vaccination on the Coexistence of Two Pneumococcal Serotypes. Epidemiol Infect; 132 (6): 1073-1081; December, 2004.

Back to Top